Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Deffered Revenue (2020 - 2021)

Terns Pharmaceuticals' Non-Current Deffered Revenue history spans 2 years, with the latest figure at $160000.0 for Q4 2021.

  • For Q4 2021, Non-Current Deffered Revenue fell 27.27% year-over-year to $160000.0; the TTM value through Dec 2021 reached $160000.0, down 27.27%, while the annual FY2021 figure was $160000.0, 27.27% down from the prior year.
  • Non-Current Deffered Revenue reached $160000.0 in Q4 2021 per TERN's latest filing, down from $176000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $220000.0 in Q4 2020 to a low of $160000.0 in Q4 2021.